(Q49106173)

18 February 2018

title

Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus. (English)

1 reference

18 February 2018

0 references

0 references

Ohnuma T

1

1 reference

18 February 2018

Tessler S

2

1 reference

18 February 2018

Arai H

3

1 reference

18 February 2018

Faull RL

4

1 reference

18 February 2018

McKenna PJ

5

1 reference

18 February 2018

Emson PC

6

1 reference

18 February 2018

publication date

1 December 2000

1 reference

18 February 2018

published in

Molecular Brain Research

1 reference

18 February 2018

volume

85

1 reference

18 February 2018

issue

1-2

1 reference

18 February 2018

page(s)

24-31

1 reference

18 February 2018

Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Metabotropic glutamate receptors: an original family of G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Recent advances in the neuropathology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

The phencyclidine-glutamate model of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Terminal coma affects messenger RNA detection in post mortem human temporal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Amelioration of negative symptoms in schizophrenia by glycine.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Extensive postmortem stability of RNA from rat and human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Molecular cloning and the functional expression of two isoforms of human metabotropic glutamate receptor subtype 5

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Molecular diversity of glutamate receptors and implications for brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Notes from the graveyard: neuropathology and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Connections of the parahippocampal cortex. I. Cortical afferents.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Metabotropic glutamate receptors in brain function and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Evidence of glutamatergic deficiency in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. I. Temporal lobe afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. II. Frontal lobe afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Neuroanatomic/neuropathologic correlates in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Glycine therapy of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-328X%2800%2900222-9

7 January 2021

10.1016/S0169-328X(00)00222-9

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

11146103

1 reference

18 February 2018